ÂÜÀòÂÒÂ×

Willem Heydendael is an accomplished medical affairs professional with extensive experience in neurology and hematology/oncology. They have successfully collaborated with cross-functional teams and provided strategic guidance in areas such as Alzheimer’s, sleep/wake disorders, and epilepsy. Willem has played a key role in the launch and label expansion of multiple treatments, demonstrating a commitment to excellence and personal growth. Their academic background includes a PhD in Neuropharmacology from Albany Medical College and a Postdoctoral Fellowship in Neurobiology from the University of Pennsylvania. Currently, they are serving as Senior Director of Business Development and Strategic Lead at Red Nucleus.